Stroke

被引:2356
作者
Donnan, Geoffrey A. [1 ]
Fisher, Marc [2 ]
Macleod, Malcolm [3 ]
Davis, Stephen M. [4 ]
机构
[1] Univ Melbourne, Natl Stroke Res Inst, Austin Hosp, Melbourne, Vic, Australia
[2] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01605 USA
[3] Stirling Royal Infirm, Dept Neurol, Stirling, Scotland
[4] Univ Melbourne, Royal Melbourne Hosp, Dept Neurol, Melbourne, Vic 3050, Australia
关键词
D O I
10.1016/S0140-6736(08)60694-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Stroke is the second most common cause of death and major cause of disability worldwide. Because of the ageing population, the burden will increase greatly during the next 20 years, especially in developing countries. Advances have occurred in the prevention and treatment of stroke during the past decade. For patients with acute stroke, management in a stroke care unit, intravenous tissue plasminogen activator within 3 h or aspirin within 48 h of stroke onset, and decompressive surgery for supratentorial malignant hemispheric cerebral infarction are interventions of proven benefit; several other interventions are being assessed. Proven secondary prevention strategies are warfarin for patients with atrial fibrillation, endarterectomy for symptomatic carotid stenosis, antiplatelet agents, and cholesterol reduction. The most important intervention is the management of patients in stroke care units because these provide a framework within which further study might be undertaken. These advances have exposed a worldwide shortage of stroke health-care workers, especially in developing countries.
引用
收藏
页码:1612 / 1623
页数:12
相关论文
共 157 条
[1]   CLASSIFICATION OF SUBTYPE OF ACUTE ISCHEMIC STROKE - DEFINITIONS FOR USE IN A MULTICENTER CLINICAL-TRIAL [J].
ADAMS, HP ;
BENDIXEN, BH ;
KAPPELLE, LJ ;
BILLER, J ;
LOVE, BB ;
GORDON, DL ;
MARSH, EE ;
KASE, CS ;
WOLF, PA ;
BABIKIAN, VL ;
LICATAGEHR, EE ;
ALLEN, N ;
BRASS, LM ;
FAYAD, PB ;
PAVALKIS, FJ ;
WEINBERGER, JM ;
TUHRIM, S ;
RUDOLPH, SH ;
HOROWITZ, DR ;
BITTON, A ;
MOHR, JP ;
SACCO, RL ;
CLAVIJO, M ;
ROSENBAUM, DM ;
SPARR, SA ;
KATZ, P ;
KLONOWSKI, E ;
CULEBRAS, A ;
CAREY, G ;
MARTIR, NI ;
FICARRA, C ;
HOGAN, EL ;
CARTER, T ;
GURECKI, P ;
MUNTZ, BK ;
RAMIREZLASSEPAS, M ;
TULLOCH, JW ;
QUINONES, MR ;
MENDEZ, M ;
ZHANG, SM ;
ALA, T ;
JOHNSTON, KC ;
ANDERSON, DC ;
TARREL, RM ;
NANCE, MA ;
BUDLIE, SR ;
DIERICH, M ;
HELGASON, CM ;
HIER, DB ;
SHAPIRO, RA .
STROKE, 1993, 24 (01) :35-41
[2]   Time to admission in acute ischemic stroke and transient ischemic attack [J].
Agyeman, O ;
Nedeltchev, K ;
Arnold, M ;
Fischer, U ;
Remonda, L ;
Isenegger, J ;
Schroth, G ;
Mattle, HP .
STROKE, 2006, 37 (04) :963-966
[3]   Secondary stroke prevention with ximelagatran versus warfarin in patients with atrial fibrillation - Pooled analysis of SPORTIF III and V clinical trials [J].
Akins, Paul T. ;
Feldman, Harvey A. ;
Zoble, Robert G. ;
Newman, David ;
Spitzer, Stefan G. ;
Diener, Hans-Christoph ;
Albers, Gregory W. .
STROKE, 2007, 38 (03) :874-880
[4]  
Albers GW, 2003, LANCET, V362, P1691
[5]   Transient ischemic attack - Proposal for a new definition. [J].
Albers, GW ;
Caplan, LR ;
Easton, JD ;
Fayad, PB ;
Mohr, JP ;
Saver, JL ;
Sherman, DG .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (21) :1713-1716
[6]   Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke [J].
Alexandrov, AV ;
Molina, CA ;
Grotta, JC ;
Garami, Z ;
Ford, SR ;
Alvarez-Sabin, J ;
Montaner, J ;
Saqqur, M ;
Demchuk, AM ;
Moye, LA ;
Hill, MD ;
Wojner, AW ;
Al-Senani, F ;
Burgin, S ;
Calleja, S ;
Campbell, M ;
Chen, CI ;
Chernyshev, O ;
Choi, J ;
El-Mitwalli, A ;
Felberg, R ;
Ford, S ;
Garami, Z ;
Irr, W ;
Grotta, J ;
Hall, C ;
Iguchi, Y ;
Ireland, J ;
Labiche, L ;
Malkoff, M ;
Morgenstern, L ;
Noser, E ;
Okon, N ;
Piriyawat, P ;
Robinson, D ;
Shaltoni, H ;
Shaw, S ;
Uchino, K ;
Yatsu, F ;
Alvarez-Sabín, J ;
Arenillas, JF ;
Huertas, R ;
Molina, C ;
Montaner, J ;
Ribó, M ;
Rubiera, M ;
Santamarina, E ;
Saqqur, M ;
Alchtar, N ;
O'Rourke, F .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (21) :2170-2178
[7]   Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia [J].
Algra, A ;
vanGijn, J .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1996, 60 (02) :197-199
[8]   Effect of statins in stroke prevention [J].
Amarenco, P .
CURRENT OPINION IN LIPIDOLOGY, 2005, 16 (06) :614-618
[9]   Statins in stroke prevention and carotid atherosclerosis -: Systematic review and up-to-date meta-analysis [J].
Amarenco, P ;
Labreuche, J ;
Lavallée, P ;
Touboul, PJ .
STROKE, 2004, 35 (12) :2902-2909
[10]  
Amarenco P, 2006, NEW ENGL J MED, V355, P549